Treatment for women: latest news

Treatment for women resources

Treatment for women features

Treatment for women news from aidsmap

More news

Treatment for women news selected from other sources

  • BHIVA statement on Potential Safety Signal in Infants Born to Women Conceiving on Dolutegravir

    The BHIVA HIV in Pregnancy Guidelines Writing group makes the following recommendations: all women wishing to conceive should be started on folic acid 5mg OD regardless of their cART regimen; all women commencing DTG should have a negative pregnancy test prior to initiation and ongoing method of contraception documented; we advise a review of all patient records of women aged up to 50yo on DTG with regards to conception plans, documented method of contraception and current pregnancy status; we recommend that women at risk of pregnancy be contacted by their clinic to discuss the DTG safety report, which should be clearly documented, and the woman seen in person if pregnant.

    4 hours ago | British HIV Association
  • Potential safety issue affecting women living with HIV using dolutegravir at the time of conception

    WHO advises that countries and ministries follow the existing 2016 WHO Consolidated ARV Guidelines, and consider the following: Pregnant women who are taking DTG should not stop their ARV therapy and should speak with their health provider for additional guidance. If other first‐line ARVs cannot be used in women of childbearing age, DTG may be considered in cases where consistent contraception can be assured.

    21 May 2018 | World Health Organization
  • Women and HIV: invisible no longer

    Women and HIV: Invisible No Longer was a one-year project led by Sophia Forum and Terrence Higgins Trust. It aimed to set out clear recommendations for policy and service development to ensure that greater focus is given to women affected by HIV.

    09 April 2018 | Terrence Higgins Trust
  • NIH Begins Large HIV Treatment Study in Pregnant Women

    The National Institutes of Health has launched a large international study to compare the safety and efficacy of three antiretroviral treatment regimens for pregnant women living with HIV and the safety of these regimens for their infants. The study will evaluate the current preferred first-line regimen for pregnant women recommended by the World Health Organization (WHO) and two regimens containing newer antiretroviral drugs that are becoming more widely used.

    24 January 2018 | NIAID press release
  • The Best Antiretroviral Therapy for Pregnant Women? The Controversy Continues

    There's considerable controversy in an area of HIV medicine that one would think should be all but solved by now. It's what HIV treatment we should give pregnant women.

    18 October 2017 | The Body PRO
  • Alice Welbourn: WHO and the rights of women living with HIV

    A recent set of articles on HIV in pregnancy, published by The BMJ and BMJ Open, raises concerns that some combination anti-retroviral therapies (cARTs) may harm babies. This highlights the need for changes to current WHO practice towards pregnant women living with HIV, which is no doubt well-intentioned but ill thought-out.

    12 September 2017 | BMJ Opinion
  • I'm A Grandmother, I Have HIV, And I Can't Pass It On

    This is one of the biggest developments since the start of the HIV epidemic, yet people don’t know it. It means people can have sex, relationships and children, with someone living with HIV, without becoming infected. For some it can sound a bit unreal - but it’s true. And if everyone know this we could stop HIV stigma.

    19 July 2017 | HuffPost UK
  • Meds May Impact Prenatal Screening in HIV+ Patients

    Pregnant women with HIV taking integrase inhibitors at the time of their non-invasive prenatal screening test had a lower mean fetal fraction than those who were not taking the medication, a small study found here.

    08 June 2017 | MedPage Today HIV/AIDS
  • The living legacy of the Global Plan: eliminating HIV in children

    The Journal of Acquired Immune Deficiency Syndromes (JAIDS) has released a special supplement on the incredible journey of the Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (Global Plan), which documents the history of the Global Plan and outlines what the future holds as efforts to end AIDS among women, children and adolescents accelerate.

    20 April 2017 | UNAIDS
  • Study results provide critical new data to guide HIV prevention and treatment efforts for women and girls

    Multiple studies discussed today in an official press briefing at the 21st International AIDS Conference (AIDS 2016) in Durban collectively provide new insights that will help shape future HIV prevention and treatment efforts for women and girls.

    18 July 2016 | AIDS 2016
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.